Key result
Diuretics and CCBs linked to ~9% lower recurrent stroke risk following ischemic stroke.
Why the study?
To evaluate the impact of various antihypertensive drugs on secondary stroke prevention in a real-life setting.
Do various antihypertensive drugs reduce the risk of stroke recurrence and MACE in adults with a history of ischaemic stroke?
Cohort (n=72,724)
Yes
Do various antihypertensive drugs reduce the risk of stroke recurrence and MACE in adults with a history of ischaemic stroke?
In a real-world cohort of patients with prior ischaemic stroke, diuretics and calcium channel blockers were associated with a reduced risk of recurrent stroke, while most antihypertensives reduced overall MACE or death.
Answers are grounded in this paper and cite their sources.
May support diuretic or CCB preference post-stroke without AF; leaves open causal confirmation in RCTs.
Objectives To evaluate the impact of various antihypertensive drugs on secondary stroke prevention in a real-life setting. Design Nationwide historic cohort study. Setting French healthcare system data (SNDS). Participants Adults hospitalised for ischaemic stroke between 2014 and 2015 were followed up until December 2021 and stratified based on the presence of atrial fibrillation (AF). Outcome measures Risk of stroke recurrence was assessed using a time-dependent Cox cause-specific model accounting for changes in drug exposure. We also investigated the risk of major adverse cardiovascular events (MACE) or all-cause death. Models were adjusted on stroke characteristics, coprescriptions and co-morbidities, at inclusion and across follow-up. Results Among 54 764 patients without AF (median age 71; 46% women) and 17 960 with AF (median age 79; 51% women), stroke recurrence occurred in 11% and 13%, respectively. In non-AF patients, reduced recurrence risk was associated only with use of calcium channel blockers (adjusted HR (aHR) 0.91, 95% CI 0.86 to 0.97), thiazide diuretics (aHR 0.90, 95% CI 0. 83 to 0.97), loop diuretics (aHR 0.86, 95% CI 0.77 to 0.95) and potassium-sparing agents (aHR 0.83, 95% CI 0.70 to 0.98). In AF patients, only potassium-sparing agents (aHR 0.82, 95% CI 0.69 to 0.99) were associated with reduced recurrence risk. All antihypertensive drugs, apart from loop diuretics, were associated with a reduced risk of MACE or all-cause death. Conclusions In this large cohort, only diuretics and calcium channel blockers were associated with a reduced risk of recurrent stroke. Most antihypertensive drugs, however, may be more effective in overall cardiovascular prevention.
No takes yet. Share an insight, caveat, or question.
Perrier et al. (2025) conducted a cohort in Ischaemic stroke (n=72,724). Antihypertensive drugs vs. Changes in drug exposure (time-dependent) was evaluated on Risk of stroke recurrence (aHR 0.91, 95% CI 0.86-0.97). Only diuretics and calcium channel blockers were associated with a reduced risk of recurrent stroke in patients with prior ischaemic stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: